摘要
Abstract
Objective To study and analyze the cost-effectiveness of three domestic proton pump inhibitors in the treatment of reflux esophagitis. Methods 90 patients with reflux esophagitis cured in our hospital from January 2015 to January 2016 were selected as the research object, and they were randomly divided into three groups, including 30 cases of group A, which were treated with Enteric-coated Tablets (Ding Qier) lOmg, 2 /d, morning and evening meals oral,30 cases of group B, which were treated with Omeprazole Enteric-coated Capsules (Jin Aokang) 20 / Mg, 2 /d, morning and evening meals oral, and group Cof 30 cases, which were treated with esomeprazole enteric coated capsules (lesmills Shu) mg / 20 times, 2 times /d, morning and evening meals oral. After 8 weeks treatment, the curative effect was evaluated by gastroscopy, and the C/E value and sensitivity of the three groups were compared. Results The total effective rate of the three groups after treatment were 96.7%, 90%, 93.3%, and the difference was not statistically significant (P>0.05). The C/E of group A was the least, and it showed that the cost effectiveness of the treatment of Bella in the treatment of reflux esophagitis was the best. Sensitivity analysis results showed that the cost effectiveness was consistent with the original analysis. Conclusion The three kinds of proton pump inhibitors in the treatment of reflux esophagitis are achieved good curative effect, but from the perspective of pharmacoeconomics, ray Bella with the treatment of reflux esophagitis has better economic effect. It is the more economical and effective choice.关键词
反流性食管炎/雷贝拉唑钠肠溶片/奥美拉唑肠溶胶囊/埃索美拉唑肠溶胶囊Key words
Reflux esophagitis/Rabeprazole sodium enteric-coated tablets/Omeprazole enteric-coated capsules/Esomeprazole enteric coated capsules分类
医药卫生
